124 related articles for article (PubMed ID: 16644320)
1. Multifaceted intervention to promote beta-blocker use in heart failure.
LaPointe NM; DeLong ER; Chen A; Hammill BG; Muhlbaier LH; Califf RM; Kramer JM
Am Heart J; 2006 May; 151(5):992-8. PubMed ID: 16644320
[TBL] [Abstract][Full Text] [Related]
2. Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure.
Ansari M; Shlipak MG; Heidenreich PA; Van Ostaeyen D; Pohl EC; Browner WS; Massie BM
Circulation; 2003 Jun; 107(22):2799-804. PubMed ID: 12756157
[TBL] [Abstract][Full Text] [Related]
3. Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline.
Peters-Klimm F; Müller-Tasch T; Remppis A; Szecsenyi J; Schellberg D
J Eval Clin Pract; 2008 Oct; 14(5):823-9. PubMed ID: 19018915
[TBL] [Abstract][Full Text] [Related]
4. The AHCPR guidelines on heart failure: comparison of a family medicine and an internal medicine practice with the guidelines and an educational intervention to modify behavior.
Chodoff P; Bischof RO; Nash DB; Laine C
Clin Perform Qual Health Care; 1996; 4(4):179-85. PubMed ID: 10162148
[TBL] [Abstract][Full Text] [Related]
5. Translation of clinical trial results into practice: temporal patterns of beta-blocker utilization for heart failure at hospital discharge and during ambulatory follow-up.
Patel P; White DL; Deswal A
Am Heart J; 2007 Apr; 153(4):515-22. PubMed ID: 17383287
[TBL] [Abstract][Full Text] [Related]
6. Use of beta-blockers in patients with an implantable cardioverter defibrillator.
LaPointe NM; Stafford JA; Pappas PA; Al-Khatib SM; Anstrom KJ
Ann Pharmacother; 2009 Jul; 43(7):1189-96. PubMed ID: 19567655
[TBL] [Abstract][Full Text] [Related]
7. Prescription patterns of pharmacological agents for left ventricular systolic dysfunction among hemodialysis patients.
Roy P; Bouchard J; Amyot R; Madore F
Am J Kidney Dis; 2006 Oct; 48(4):645-51. PubMed ID: 16997061
[TBL] [Abstract][Full Text] [Related]
8. Association between functional status and use and effectiveness of beta-blocker prophylaxis in elderly survivors of acute myocardial infarction.
Vitagliano G; Curtis JP; Concato J; Feinstein AR; Radford MJ; Krumholz HM
J Am Geriatr Soc; 2004 Apr; 52(4):495-501. PubMed ID: 15066062
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF.
Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
J Card Fail; 2007 Nov; 13(9):722-31. PubMed ID: 17996820
[TBL] [Abstract][Full Text] [Related]
10. Preoperative beta-blocker use: impact of national guidelines on clinical practice.
Akhtar S; Assaad S; Amin M; Holt NF; Barash PG; Silverman DG
J Clin Anesth; 2008 Mar; 20(2):122-8. PubMed ID: 18410867
[TBL] [Abstract][Full Text] [Related]
11. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure.
Fauchier L; Grimard C; Pierre B; Nonin E; Gorin L; Rauzy B; Cosnay P; Babuty D; Charbonnier B
Am J Cardiol; 2009 Jan; 103(2):248-54. PubMed ID: 19121446
[TBL] [Abstract][Full Text] [Related]
12. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
Pascual-Figal DA; Redondo B; Caro C; Manzano S; Garrido IP; Ruipérez JA; Valdés M
Am J Cardiol; 2008 Dec; 102(12):1711-7. PubMed ID: 19064029
[TBL] [Abstract][Full Text] [Related]
13. Prescription patterns in patients with systolic heart failure at hospital discharge: why beta blockers are underprescribed or prescribed at low dose in real life?
Yilmaz MB; Refiker M; Guray Y; Guray U; Altay H; Demirkan B; Caldir V; Korkmaz S
Int J Clin Pract; 2007 Feb; 61(2):225-30. PubMed ID: 17263710
[TBL] [Abstract][Full Text] [Related]
14. Analysis of ambulatory heart failure management and its incidence on one-year survival.
Allaert FA; Mosnier M
Ann Cardiol Angeiol (Paris); 2008 Feb; 57(1):22-8. PubMed ID: 18054890
[TBL] [Abstract][Full Text] [Related]
15. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
[TBL] [Abstract][Full Text] [Related]
16. The impact of patient-specific quality-of-care report cards on guideline adherence in heart failure.
Matthews JC; Johnson ML; Koelling TM
Am Heart J; 2007 Dec; 154(6):1174-83. PubMed ID: 18035092
[TBL] [Abstract][Full Text] [Related]
17. How well are chronic heart failure patients being managed?
Fonarow GC
Rev Cardiovasc Med; 2006; 7 Suppl 1():S3-11. PubMed ID: 16955055
[TBL] [Abstract][Full Text] [Related]
18. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
[TBL] [Abstract][Full Text] [Related]
19. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
Fonarow GC; Stough WG; Abraham WT; Albert NM; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
J Am Coll Cardiol; 2007 Aug; 50(8):768-77. PubMed ID: 17707182
[TBL] [Abstract][Full Text] [Related]
20. Optimizing beta-blocker use after myocardial infarction.
Howard PA; Ellerbeck EF
Am Fam Physician; 2000 Oct; 62(8):1853-60, 1865-6. PubMed ID: 11057841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
